FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4387241519> ?p ?o ?g. }

• W4387241519 abstract "Malnutrition and subsequent alterations in body composition (BC), particularly sarcopenia, are common but not yet elucidated in patients with inflammatory bowel disease (IBD); we aimed to detail the changes in BC and the characteristics of co-occurrence of malnutrition and sarcopenia in IBD patients and to investigate its effect on quality of life.This study was a multicentre, prospective, observational study involving four tertiary referral hospitals in China. The following data were collected from consecutive IBD inpatients: demographic information, medical history, recent weight change, handgrip strength (HGS) and BC parameters by bioelectrical impedance analysis (BIA). Nutritional assessments were performed through stepwise screening (Nutritional Risk Screening 2002) and diagnosis (World Health Organization-related body mass index [BMI], subjective global assessment, European Society for Clinical Nutrition and Metabolism 2015 and Global Leadership Initiative on Malnutrition [GLIM] criteria). The quality of life was assessed by the Inflammatory Bowel Disease Questionnaire. IBD patients were compared with 1:1 sex-, age- and BMI-matched healthy controls (MHC).A total of 238 IBD patients (177 Crohn's disease [CD] and 61 ulcerative colitis [UC]), 68.5% male, with a mean age of 38.5 ± 14.0 years and a mean BMI of 19.8 ± 3.5 kg/m2 , were recruited. Compared with MHC (n = 122), IBD patients showed significant deterioration in BC and physical function, characterized by muscle depletion (appendicular skeletal muscle mass index [ASMI], 8.0 ± 1.3 vs. 6.7 ± 1.2 kg/m2 , Δ% -15.0% [-22.0%, -10.0%], P < 0.001) and fat accumulation (visceral fat area, 32.9 ± 22.6 vs. 66.5 ± 35.8, Δ% 110.0% [35.0%, 201.0%], P < 0.001). The prevalence of GLIM-defined malnutrition and sarcopenia in IBD patients was 60.1% and 25.2%, respectively. The nutritional status of patients with CD was worse than that of patients with UC. The activity phase of IBD significantly and negatively affected BC, while the lesion location did not. The co-occurrence of sarcopenia and malnutrition was not optimistic; 16.4-21.8% of patients suffer from sarcopenia and malnutrition based on different criteria at the same time, which was accompanied by a reduction in quality of life. HGS was correlated with various BC parameters (body cell mass, r = 0.76; ASMI, r = 0.70; fat-free mass, r = 0.73, all P < 0.001).GLIM-defined malnutrition and sarcopenia were prevalent in IBD patients and kept a high rate of co-occurrence, which was accompanied with impaired quality of life. The alteration of BC in IBD patients was characterized by muscle depletion and fat accumulation. The strong correlation between HGS and BIA-derived BC suggested its hopeful evaluation in nutritional status and sarcopenia in IBD patients." @default.
• W4387241519 created "2023-10-03" @default.
• W4387241519 creator A5010478248 @default.
• W4387241519 creator A5014294522 @default.
• W4387241519 creator A5021520609 @default.
• W4387241519 creator A5022731359 @default.
• W4387241519 creator A5029604154 @default.
• W4387241519 creator A5035588677 @default.
• W4387241519 creator A5050266554 @default.
• W4387241519 creator A5066716873 @default.
• W4387241519 creator A5069139562 @default.
• W4387241519 creator A5069406479 @default.
• W4387241519 creator A5071867794 @default.
• W4387241519 creator A5079424822 @default.
• W4387241519 creator A5082151648 @default.
• W4387241519 date "2023-10-01" @default.
• W4387241519 modified "2023-10-03" @default.
• W4387241519 title "Impact of malnutrition and sarcopenia on quality of life in patients with inflammatory bowel disease: A multicentre study" @default.
• W4387241519 cites W1054573222 @default.
• W4387241519 cites W1878034335 @default.
• W4387241519 cites W1980206322 @default.
• W4387241519 cites W1982052873 @default.
• W4387241519 cites W1993741048 @default.
• W4387241519 cites W1999181657 @default.
• W4387241519 cites W2000003925 @default.
• W4387241519 cites W2043780358 @default.
• W4387241519 cites W2092182163 @default.
• W4387241519 cites W2102013054 @default.
• W4387241519 cites W2142037420 @default.
• W4387241519 cites W2171789845 @default.
• W4387241519 cites W2538297243 @default.
• W4387241519 cites W2561294066 @default.
• W4387241519 cites W2733939586 @default.
• W4387241519 cites W2737265887 @default.
• W4387241519 cites W2750671834 @default.
• W4387241519 cites W2758550417 @default.
• W4387241519 cites W2889190379 @default.
• W4387241519 cites W2900355565 @default.
• W4387241519 cites W2952797756 @default.
• W4387241519 cites W2954816201 @default.
• W4387241519 cites W2956907576 @default.
• W4387241519 cites W2976367409 @default.
• W4387241519 cites W2983457235 @default.
• W4387241519 cites W2999392094 @default.
• W4387241519 cites W3005437800 @default.
• W4387241519 cites W3044634781 @default.
• W4387241519 cites W3087478081 @default.
• W4387241519 cites W3207525071 @default.
• W4387241519 cites W3208917099 @default.
• W4387241519 cites W4206934190 @default.
• W4387241519 cites W4214924099 @default.
• W4387241519 cites W4224304580 @default.
• W4387241519 cites W4231015464 @default.
• W4387241519 cites W4286492739 @default.
• W4387241519 cites W4292371222 @default.
• W4387241519 doi "https://doi.org/10.1002/jcsm.13341" @default.
• W4387241519 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37779327" @default.
• W4387241519 hasPublicationYear "2023" @default.
• W4387241519 type Work @default.
• W4387241519 citedByCount "0" @default.
• W4387241519 crossrefType "journal-article" @default.
• W4387241519 hasAuthorship W4387241519A5010478248 @default.
• W4387241519 hasAuthorship W4387241519A5014294522 @default.
• W4387241519 hasAuthorship W4387241519A5021520609 @default.
• W4387241519 hasAuthorship W4387241519A5022731359 @default.
• W4387241519 hasAuthorship W4387241519A5029604154 @default.
• W4387241519 hasAuthorship W4387241519A5035588677 @default.
• W4387241519 hasAuthorship W4387241519A5050266554 @default.
• W4387241519 hasAuthorship W4387241519A5066716873 @default.
• W4387241519 hasAuthorship W4387241519A5069139562 @default.
• W4387241519 hasAuthorship W4387241519A5069406479 @default.
• W4387241519 hasAuthorship W4387241519A5071867794 @default.
• W4387241519 hasAuthorship W4387241519A5079424822 @default.
• W4387241519 hasAuthorship W4387241519A5082151648 @default.
• W4387241519 hasBestOaLocation W43872415191 @default.
• W4387241519 hasConcept C126322002 @default.
• W4387241519 hasConcept C159110408 @default.
• W4387241519 hasConcept C1862650 @default.
• W4387241519 hasConcept C2776214593 @default.
• W4387241519 hasConcept C2778260677 @default.
• W4387241519 hasConcept C2779134260 @default.
• W4387241519 hasConcept C2779280984 @default.
• W4387241519 hasConcept C2779951463 @default.
• W4387241519 hasConcept C2780221984 @default.
• W4387241519 hasConcept C2780479503 @default.
• W4387241519 hasConcept C2780586474 @default.
• W4387241519 hasConcept C33872192 @default.
• W4387241519 hasConcept C551997983 @default.
• W4387241519 hasConcept C71924100 @default.
• W4387241519 hasConcept C90924648 @default.
• W4387241519 hasConceptScore W4387241519C126322002 @default.
• W4387241519 hasConceptScore W4387241519C159110408 @default.
• W4387241519 hasConceptScore W4387241519C1862650 @default.
• W4387241519 hasConceptScore W4387241519C2776214593 @default.
• W4387241519 hasConceptScore W4387241519C2778260677 @default.
• W4387241519 hasConceptScore W4387241519C2779134260 @default.
• W4387241519 hasConceptScore W4387241519C2779280984 @default.
• W4387241519 hasConceptScore W4387241519C2779951463 @default.
• W4387241519 hasConceptScore W4387241519C2780221984 @default.
• W4387241519 hasConceptScore W4387241519C2780479503 @default.

• next